Mapatumumab, an antibody targeting TRAIL-R1, in combination with paclitaxel and carboplatin in patients with advanced solid malignancies: results of a phase I and pharmacokinetic study.
暂无分享，去创建一个
M. von Mehren | D. Camidge | L. Chow | S. Leong | C. Langer | R. Cohen | D. Gustafson | N. Fox | S. Diab | S. Eckhardt | L. Gore | C. O’Bryant | K. Padavic | R. Miceli | S. Hariharan | Margaret Smith | Margaret R. Smith | Corey J. Langer | D. Camidge | C. Langer | Daniel L. Gustafson | Laura Q. Chow